Economic Evaluation of Treatments for Respiratory Disease
- 1 September 1992
- journal article
- Published by Springer Nature in PharmacoEconomics
- Vol. 2 (3) , 207-218
- https://doi.org/10.2165/00019053-199202030-00004
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Cost-effectiveness analysis: is it ethical?Journal of Medical Ethics, 1992
- Principles of Pharmacoeconomic Analysis of Drug TherapyPharmacoEconomics, 1992
- A randomized, controlled comparison of isoetharine and albuterol in the treatment of acute asthmaAnnals of Emergency Medicine, 1991
- Has the prevalence of asthma increased in children? Evidence from the national study of health and growth 1973-86.BMJ, 1990
- Changes in asthma prevalence: two surveys 15 years apart.Archives of Disease in Childhood, 1989
- Specialty differences in the treatment of asthmaJournal of Allergy and Clinical Immunology, 1989
- Aerosol bronchodilator delivery methods. Relative impact on pulmonary function and cost of respiratory careArchives of internal medicine (1960), 1989
- Measuring the effectiveness of heart transplant programmes: Quality of life data and their relationship to survival analysisJournal of Chronic Diseases, 1987
- Evaluation of the addition of cromolyn sodium to bronchodilator maintenance therapy in the long-term management of asthmaJournal of Allergy and Clinical Immunology, 1987
- A Controlled Trial of Methylprednisolone in the Emergency Treatment of Acute AsthmaNew England Journal of Medicine, 1986